5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to fluorouracil
Related studies linked through entity extraction aliases.
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
PEN-866 in Patients With Advanced Solid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
- Status
- COMPLETED
- Phase
- PHASE3
FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
- Status
- WITHDRAWN
- Phase
- PHASE2
mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA
- Status
- UNKNOWN
- Phase
- NA
Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
- Status
- SUSPENDED
- Phase
- PHASE2
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- EARLY_PHASE1